Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue
A technology for ciliary nerve nutrition and stabilization of pharmaceuticals, which is applied to medical preparations containing active ingredients, nervous system diseases, and medical preparations with non-active ingredients, etc. It can solve the problems of stability comparison and achieve the effect of convenient transportation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0069] The various stabilizers listed in Table 1 are added to 0.2 mg / ml ciliary neurotrophic factor analogue (its amino acid composition is the same as sequence 1 in the accompanying drawing), containing 10mM pH7.0 phosphate buffer saline in the mixture, without After bacterial filtration, 0.5 ml / cartridge is sealed in a glass vial. Observe its changes under different conditions. Measured by method (A), the results are shown in Table 1. Wherein "activity (%)" represents the remaining ciliary neurotrophic factor analogue activity amount compared with the initial one.
[0070] stabilizer
Embodiment 2
[0072] Several stabilizing agents listed in table 2 are added to 0.2 mg / ml ciliary neurotrophic factor analog (its amino acid composition is the same as sequence 2 in the accompanying drawing), the mixture contains the inorganic salt buffer solution of 10mM different pH, without After bacterial filtration, it is sealed in a bottle at a rate of 0.5 ml / cartridge. Observe its changes under different conditions. Measured by method (B), the results are shown in Table 2.
[0073] stabilizer
Embodiment 3
[0075] The various stabilizers listed in Table 3 are added to 0.2 mg / ml ciliary neurotrophic factor analog (its amino acid composition is the same as sequence 1 in the accompanying drawing), and the mixture contains pH7.0 in 20mM phosphate buffer , after sterile filtration, it is divided into glass vials at 0.5 ml / branch. Then lyophilize according to the following procedure: freeze at -35°C or below -35°C for 4 hours, then perform the first drying for 10 hours, heat from -35°C to -5°C, increase the pressure from 0.015 Torr to 0.2 Torr, and then For the second drying, the temperature is heated from -5°C to 30°C, the pressure is reduced from 0.2 torr to 0.05 torr, and then sterilized dry nitrogen is filled into the inside of the vial to make it reach an atmospheric pressure, and the vial is placed under aseptic conditions. Stoppered and finally sealed with an aluminum cap. Observe its changes under different conditions. Measured by method (B), the results are shown in Table 3....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com